| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $169K | — | — |
| R&D Expense | $15.0M | — | +126.6% |
| SG&A Expense | $4.7M | — | -1.4% |
| Operating Income | -$19.6M | — | -71.3% |
| Pre-tax Income | -$19.4M | — | -89.4% |
| Income Tax | $48K | — | -11.1% |
| Net Income | -$19.4M | — | -88.8% |
| EPS (Basic) | -$0.34 | — | -78.9% |
| EPS (Diluted) | -$0.34 | — | -78.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $46.0M | +20.1% | -3.5% |
| Short-term Investments | $0 | -100.0% | -100.0% |
| Accounts Receivable | $0 | -100.0% | -100.0% |
| Current Assets | $55.0M | +8.0% | -37.3% |
| Total Assets | $60.1M | +7.1% | -35.2% |
| Current Liabilities | $17.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$16.0M | — | -60.7% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | $6.0M | — | +129.1% |
| Financing Cash Flow | $17.6M | — | — |
| Free Cash Flow | -$16.0M | — | -59.4% |
| +99.0% |
| Total Liabilities | $17.4M | +23.8% | +78.2% |
| Stockholders' Equity | $42.6M | +1.5% | -48.6% |